Bacterial Biofilm Infections and Treatment
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Bacterial Pathogens".
Deadline for manuscript submissions: closed (30 December 2023) | Viewed by 17780
Special Issue Editor
Special Issue Information
Dear Colleagues,
Biofilms are responsible for most microbial infections in the human body because of their ability to evade detection, resist immune attack and withstand antimicrobial treatment. Despite the enormous efforts of academic researchers, clinicians and industry in recent years, many biofilm pathogenesis mechanisms remain unanswered. Hence, it is imperative to develop new strategies to control biofilm infections. This Special Issue plans to give an overview of the most recent advances in biofilm research, and aims to present selected contributions on biofilm infections, antimicrobial tolerance and the development of antibiofilm agents. Potential topics include, but are not limited to: biofilm pathogenesis; biofilm mechanisms, including c-di-GMP signaling and quorum sensing; host–biofilm interactions; biofilm tolerance to antimicrobials; the detection of biofilm infections; the role of biofilms in clinical settings; the discovery and evaluation of antibiofilm agents, including quorum-sensing inhibitors and biofilm-degrading enzymes; antibiofilm chemotherapy in clinical settings; and future perspectives of biofilm infections and chemotherapy. We welcome the submission of original research articles, communications, or reviews focused on the mechanisms of biofilm pathogenesis or novel compounds intended to mitigate it. All submitted papers will undergo a standard independent peer-review process.
Dr. Songlin Chua
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biofilms
- infection
- antibiotic tolerance
- antibiofilm agents
- treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.